2018 Cholangiocarcinoma Annual Conference

2018 Cholangiocarcinoma Annual Conference

Programme du congrès

Lieu : Utah

Pays : Etats-Unis

Langue : ENG

Date de début :

Date de fin :

Spécialités : Oncologie

The Cholangiocarcinoma Foundation's Annual Conference seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma

Toutes les vidéos du congrès ( 50 vidéos )

Suggérer une vidéo

Day 2 - Mitochondrial Dysfunction

Day 2 - Mitochondrial Dysfunction
  • Date : 02/02/2021
  • 1    
    0

Day 1 - Social Media

Day 1 - Social Media
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Molecular Pathology

Day 2 - Molecular Pathology
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Genomics of CCA

Day 2 - Genomics of CCA
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Patient Perspective

Day 2 - Patient Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 2 - ICRN Update

Day 2 - ICRN Update
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Panel Discussion

Day 2 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Global Risk Factors

Day 2 - Global Risk Factors
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Patterns/Outcomes from CCA DB

Day 2 - Patterns/Outcomes from CCA DB
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Incidence of Cholangiocarcinoma

Day 2 - Incidence of Cholangiocarcinoma
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Welcome

Day 2 - Welcome
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Caregiver Perspective

Day 1 - Caregiver Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 1 - CholangioConnect

Day 1 - CholangioConnect
  • Date : 02/02/2021
  • 0    
    0

Day 2 - FGFR Signaling

Day 2 - FGFR Signaling
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Advocacy Update

Day 1 - Advocacy Update
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Nurturing Hope

Day 1 - Nurturing Hope
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Complimentary Medicine

Day 1 - Complimentary Medicine
  • Date : 02/02/2021
  • 0    
    0

Day 1 - PCORI

Day 1 - PCORI
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Cancer & Nutrition

Day 1 - Cancer & Nutrition
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Management of Biliary Obstruction

Day 1 - Management of Biliary Obstruction
  • Date : 02/02/2021
  • 0    
    0

Day 1 - FDA Drug Approval Process

Day 1 - FDA Drug Approval Process
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Immunotherapies

Day 1 - Immunotherapies
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Epidemiology of Cholangiocarcinoma

Day 1 - Epidemiology of Cholangiocarcinoma
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Patient Perspective

Day 1 - Patient Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Welcome/CCF Update

Day 1 - Welcome/CCF Update
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Basic Research Update

Day 1 - Basic Research Update
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Hippo Signaling Pathways

Day 2 - Hippo Signaling Pathways
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Panel Discussion

Day 3 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 3 - FDA Expedited Programs

Day 3 - FDA Expedited Programs
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Biomarker Data from ABC-06

Day 3 - Biomarker Data from ABC-06
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Clinical Trial Design

Day 3 - Clinical Trial Design
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Systemic Therapy for CCA

Day 3 - Systemic Therapy for CCA
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Nursing Advisory Board

Day 3 - Nursing Advisory Board
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Panel Discussion

Day 3 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Adjuvant Therapy

Day 3 - Adjuvant Therapy
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Novel Approaches to Radiotherapy

Day 3 - Novel Approaches to Radiotherapy
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Intrahepatic CCA

Day 3 - Intrahepatic CCA
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Patient Perspective

Day 3 - Patient Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Closing Remarks

Day 3 - Closing Remarks
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Immunotherapy

Day 2 - Immunotherapy
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Next Generation Mouse Model

Day 2 - Next Generation Mouse Model
  • Date : 02/02/2021
  • 0    
    0

Day 2 - A Distributed Hepaocyte

Day 2 - A Distributed Hepaocyte
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Panel Discussion

Day 2 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 2 - IDH Mutations

Day 2 - IDH Mutations
  • Date : 02/02/2021
  • 0    
    0

Day 2 - IDH Inhibitor Trials

Day 2 - IDH Inhibitor Trials
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Liabilities of IDH Mutant Cells

Day 2 - Liabilities of IDH Mutant Cells
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Volunteer Meeting

Day 2 - Volunteer Meeting
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Panel Discussion

Day 2 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 2 - FGFR Inhibition

Day 2 - FGFR Inhibition
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Targeting The Hippo Pathway

Day 2 - Targeting The Hippo Pathway
  • Date : 02/02/2021
  • 0    
    0

Sélection de congrès

ESMO Gynaecological Cancers Congress 2024

ESMO Gynaecological Cancers Congress 2024
  • Date : 20/06/2024
  • 10736    
    0

SIFEM 2024

SIFEM 2024
  • Date : 13/06/2024
  • 2062    
    0

Annual Meeting on Women's Cancer SGO 2024

Annual Meeting on Women's Cancer SGO 2024
  • Date : 16/03/2024
  • 1891    
    0

43ème Réunion interdisciplinaire de chimiothérapie anti-infectieuse

43ème Réunion interdisciplinaire de chimiothérapie anti-infectieuse
  • Date : 18/12/2023
  • 10232    
    0

13e Congrès National des réseaux en Cancérologie - CNRC 2023

13e Congrès National des réseaux en Cancérologie - CNRC 2023
  • Date : 09/11/2023
  • 7332    
    0